The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN
Status PubMed-not-MEDLINE Language English Country England, Great Britain Media electronic-ecollection
Document type Journal Article
PubMed
35983540
PubMed Central
PMC9379353
DOI
10.1183/23120541.00139-2022
PII: 00139-2022
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterised by impaired mucociliary clearance leading to irreversible lung damage. In contrast to other rare lung diseases like cystic fibrosis (CF), there are only few clinical trials and limited evidence-based treatments. Management is mainly based on expert opinions and treatment is challenging due to a wide range of clinical manifestations and disease severity. To improve clinical and translational research and facilitate development of new treatments, the clinical trial network for PCD (PCD-CTN) was founded in 2020 under the framework of the European Reference Network (ERN)-LUNG PCD Core. Applications from European PCD sites interested in participating in the PCD-CTN were requested. Inclusion criteria consisted of patient numbers, membership of ERN-LUNG PCD Core, use of associated standards of care, experience in PCD and/or CF clinical research, resources to run clinical trials, good clinical practice (GCP) certifications and institutional support. So far, applications from 22 trial sites in 18 European countries have been approved, including >1400 adult and >1600 paediatric individuals with PCD. The PCD-CTN is headed by a coordinating centre and consists of a steering and executive committee, a data safety monitoring board and committees for protocol review, training and standardisation. A strong association with patient organisations and industrial companies are further cornerstones. All participating trial sites agreed on a code of conduct. As CTNs from other diseases have demonstrated successfully, this newly formed PCD-CTN operates to establish evidence-based treatments for this orphan disease and to bring new personalised treatment approaches to patients.
Association des Patients Ayant une Dyskinésie Ciliaire Primitive Saint Etienne France
Dept of General Pediatrics University Hospital Muenster Muenster Germany
Dept of Pediatric Pulmonology Hacettepe University Faculty of Medicine Ankara Turkey
Dept of Pediatrics University Hospital Leuven Leuven Belgium
Dept of Pulmonology Amsterdam UMC Location AMC Amsterdam the Netherlands
Dept of Respiratory Medicine Amsterdam UMC University of Amsterdam Amsterdam the Netherlands
Dept of Respiratory Medicine Hannover Medical School and DZL Hannover Germany
Dept of Respiratory Medicine University Hospitals of Leicester Leicester UK
German Center for Lung Research Berlin Germany
Kartagener Syndrom and Primäre Ciliäre Dyskinesie e V Hannover Germany
Medical School University of Cyprus Nicosia Cyprus
Paediatric Pulmonology Unit Hospital Clínico Universitario Valencia Valencia Spain
PCD Diagnosis and Research Dept of Respiratory Sciences University of Leicester Leicester UK
Primary Ciliary Dyskinesia Management Centre Leeds Teaching Hospitals NHS Trust Leeds UK
Pulmonology and Allergology Section Unit of Pediatrics Pisa University Hospital Pisa Italy
See more in PubMed
Wallmeier J, Nielsen KG, Kuehni CE, et al. . Motile ciliopathies. Nat Rev Dis Primers 2020; 6: 77. doi:10.1038/s41572-020-0209-6 PubMed DOI
Ardura-Garcia C, Goutaki M, Carr SB, et al. . Registries and collaborative studies for primary ciliary dyskinesia in Europe. ERJ Open Res 2020; 6: 00005-2020. doi:10.1183/23120541.00005-2020 PubMed DOI PMC
Marthin JK, Petersen N, Skovgaard LT, et al. . Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study. Am J Respir Crit Care Med 2010; 181: 1262–1268. doi:10.1164/rccm.200811-1731OC PubMed DOI
Frija-Masson J, Bassinet L, Honoré I, et al. . Clinical characteristics, functional respiratory decline and follow-up in adult patients with primary ciliary dyskinesia. Thorax 2017; 72: 154–160. doi:10.1136/thoraxjnl-2015-207891 PubMed DOI
Hayes D, Reynolds SD, Tumin D. Outcomes of lung transplantation for primary ciliary dyskinesia and Kartagener syndrome. J Heart Lung Transpl 2016; 35: 1377–1378. doi:10.1016/j.healun.2016.08.025 PubMed DOI
Davis SD, Rosenfeld M, Lee HS, et al. . Primary ciliary dyskinesia: longitudinal study of lung disease by ultrastructure defect and genotype. Am J Respir Crit Care Med 2019; 199: 190–198. doi:10.1164/rccm.201803-0548OC PubMed DOI PMC
Wallmeier J, Al-Mutairi DA, Chen CT, et al. . Mutations in CCNO result in congenital mucociliary clearance disorder with reduced generation of multiple motile cilia. Nat Genet 2014; 46: 646–651. doi:10.1038/ng.2961 PubMed DOI
Loges NT, Antony D, Maver A, et al. . Recessive DNAH9 loss-of-function mutations cause laterality defects and subtle respiratory ciliary-beating defects. Am J Hum Genet 2018; 103: 995–1008. doi:10.1016/j.ajhg.2018.10.020 PubMed DOI PMC
Knowles MR, Ostrowski LE, Leigh MW, et al. . Mutations in RSPH1 cause primary ciliary dyskinesia with a unique clinical and ciliary phenotype. Am J Respir Crit Care Med 2014; 189: 707–717. doi:10.1164/rccm.201311-2047OC PubMed DOI PMC
Yiallouros PK, Kouis P, Kyriacou K, et al. . Implementation of multigene panel NGS diagnosis in the national primary ciliary dyskinesia cohort of Cyprus: an island with a high disease prevalence. Hum Mutat 2021; 42: e62–e77. doi:10.1002/humu.24196 PubMed DOI
Strippoli MP, Frischer T, Barbato A, et al. . Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J 2012; 39: 1482–1491. doi:10.1183/09031936.00073911 PubMed DOI
Lucas JS, Burgess A, Mitchison HM, et al. . Diagnosis and management of primary ciliary dyskinesia. Arch Dis Child 2014; 99: 850–856. doi:10.1136/archdischild-2013-304831 PubMed DOI PMC
Mirra V, Werner C, Santamaria F. Primary ciliary dyskinesia: an update on clinical aspects, genetics, diagnosis, and future treatment strategies. Front Pediatr 2017; 5: 135. doi:10.3389/fped.2017.00135 PubMed DOI PMC
Kobbernagel HE, Buchvald FF, Haarman EG, et al. . Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial. Lancet Respir Med 2020; 8: 493–505. doi:10.1016/S2213-2600(20)30058-8 PubMed DOI
Werner C, Lablans M, Ataian M, et al. . An international registry for primary ciliary dyskinesia. Eur Respir J 2016; 47: 849–859. doi:10.1183/13993003.00776-2015 PubMed DOI
R Core Team (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. www.R-project.org/.
RStudio Team (2020). RStudio: Integrated Development Environment for R. RStudio, PBC, Boston, MA. www.rstudio.com/.
Original S code by Richard A. Becker, Allan R. Wilks. R version by Ray Brownrigg. Enhancements by Thomas P Minka and Alex Deckmyn. (2021). maps: Draw Geographical Maps. R package version 3.4.0. https://CRAN.R-project.org/package=maps.
Wickham H. ggplot2: elegant graphics for data analysis. Springer-Verlag, New York, 2016.
Wickham H, François R, Henry L,et al. (2021). dplyr: A Grammar of Data Manipulation. R package version 1.0.7. https://CRAN.R-project.org/package=dplyr.
De Boeck K, Bulteel V, Tiddens H, et al. . Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). J Cyst Fibros 2011; 10: Suppl 2, S67–S74. doi:10.1016/S1569-1993(11)60010-6 PubMed DOI
Aliberti S, Polverino E, Chalmers JD, et al. . The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS clinical research collaboration. Eur Respir J 2018; 52: 1802074. doi:10.1183/13993003.02074-2018 PubMed DOI
Brightling C, Genton C, Bill W, et al. . ERS clinical research collaborations: underpinning research excellence. Eur Respir J 2018; 52: 1801534. doi:10.1183/13993003.01534-2018 PubMed DOI
Goutaki M, Crowley S, Dehlink E, et al. . BEAT-PCD clinical research collaboration. The BEAT-PCD (Better Experimental Approaches to Treat Primary Ciliary Dyskinesia) clinical research collaboration. Eur Respir J 2021; 57: 2004601. doi:10.1183/13993003.04601-2020 PubMed DOI